Cogent Biosciences Company
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Total Funding:
282700000
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Employee Number:
101-250
Last Funding Type:
Post-IPO Equity
Founded Date:
1/1/2014
Industry:
Gene therapy